Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Alyssa R. Matuszak
Nurse Practitioner Peds Crit Care
Department of Pediatrics
Division of Critical Care
MSN, RN, CPNP-AC
OFFICE ADDRESS:
Children's Hospital
9000 W Wisconsin Ave
Milwaukee, WI 53226
Phone: 414-266-1857
Fax: 414-266-3563
Email: amatuszak@mcw.edu

EDUCATION:
09/2004 - 05/2008 Bachelor of Science, Human Biology with Health Science Emphasis, University of Wisconsin-Green Bay, Green Bay, WI
05/2010 - 08/2011 Master of Science Degree in Nursing, Acute Care Pediatric Nurse Practitioner, Marquette University, Milwaukee, WI
05/2010 - 05/2014 RN Coursework, Marquette University, Milwaukee, WI

EDUCATIONAL ADMINISTRATIVE APPOINTMENTS:
01/2013 - 05/2014 Pediatric Nurse Practitioner Student, Pediatrics, Critical Care, Children's Hospital of Wisconsin/Medical College of Wisconsin, Milwaukee, WI

HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS:
09/2008 - 04/2014 Clinical Research Nurse, Medicine, Nephrology, Medical College of Wisconsin, Milwaukee, WI
12/2011 - 06/2014 Registered Nurse - Staff Nurse/Patient Care Coordinator, NICU, Wheaton Franciscan Health Care, All Saints, Racine, WI
06/16/2014 - Present Critical Care Pediatric Nurse Practitioner, Pediatrics, Critical Care, Medical College of Wisconsin/Children’s Hospital of Wisconsin, 9000 W. Wisconsin Avenue, Milwaukee, WI 53226

RESEARCH ADMINISTRATIVE APPOINTMENTS:
06/2007 - 09/2007 Research Assistant, Adolescent Medicine, Gastroenterology, Medical College of Wisconsin, Milwaukee, WI
06/2008 - 09/2008 Research Assistant, Adolescent Medicine, Gastroenterology, Medical College of Wisconsin, Milwaukee, WI

HOSPITAL STAFF PRIVILEGES:
07/01/2014 - Present Pediatric Critical Care Nurse Practitioner, Pediatrics, Critical Care, Children's Hospital of Wisconsin/Medical College of Wisconsin, Milwaukee, WA

SPECIALTY BOARDS AND CERTIFICATION:
Certificates
Issued By Issue DateExpiration
NRP
WFHC-All Saints
01/2016
BLS
Children's Hospital of Wisconsin
04/2021
PALS
Children's Hospital of Wisconsin
04/2021
S.T.A.B.L.E.
WFHC-All Saints
05/2016
 

Licensure
Number Issue DateExpiration
RN (WI)
2011
02/2021
DEA
02/09/2014
02/2023
PNCB (Acute care)
07/25/2014
02/2021
WI APN
08/2014
09/2021
 

AWARDS AND HONORS:
2014 Summa Cum Laude Honors, Marquette University
2017 Tom B. Rice Critical Care Award for Integrity, Medical College of Wisconsin
- 2019 Tom B. Rice Critical Care Award for Integrity

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
2005 - Present Beta Beta Beta Honor Society (Member)
2013 - Present National Association of Pediatric Nurse Practitioners (NAPNAP), Wisconsin Chapter, Special interest group: Acute Care Pediatrics (Member)
2017 - Present Society of Critical Care Medicine (Member)

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
Catechol-O-Methyltransferase (COMT) Enzyme Polymorphisms as a Predictor of Outcomes for Children with Septic Shock
Source:
Children’s Hospital of Wisconsin/Medical College of Wisconsin
Role:
Co-Investigator
PI:
Nathan Thompson, M.D., PharmD
Dates:
06/2017 - Present
 
Title:
Nutrition Practices and Outcomes for Children on Non-Invasive Ventilation (NPO/NIV)
Source:
PALISI
Role:
Co-Investigator
PI:
Theresa A. Mikhailov, MD,PhD
Dates:
06/2017 - Present
 
Title:
Prevention of Central Venous Associated – Thrombosis in Critically Ill Children (CRETE)
Source:
Yale School of Medicine/American Heart Association/Eunice Kennedy Shriver National Institute of Child Health and Human Development
Role:
Co-Investigator
PI:
Sheila Hanson, MD
Dates:
06/2018 - Present
 
Prior
Non-Peer Review
Title:
Phase III, Randomized, Double-Blind, Placebo-Controlled Withdrawal Study Comparing MCI-196 vs. Placebo Following a 12-Week Dose Titration Period with MCI-196 in CKD Subjects on Dialysis (Stage V) with Hyperphosphatemia
Source:
Mitsubishi Pharma America, Inc.
Role:
Research Assistant
PI:
Blumenthal, Samuel S.
Dates:
10/2008 - 03/2010
 
Title:
Phase II, Double-Blind, Placebo-Controlled, Parallel Group, Fixed Dose Study of AMG 223 in Subjects with CKD on Hemodialysis with Hyperphosphatemia
Source:
Amgen
Role:
Research Assistant
PI:
Blumenthal, Samuel S.
Dates:
10/2008 - 04/2009
 
Title:
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of AST-120 for Prevention of Chronic Kidney Disease Progression in Patients with Moderate to Severe Chronic Kidney Disease including Assessment of Quality of Life.
Source:
Mitsubishi Pharmaceuticals, Inc.
Role:
Research Assistant
PI:
Blumenthal, Samuel S.
Dates:
10/2008 - 2012
 
Title:
PYR-210: A Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety & Efficacy of Pyridorin in T2DM Subjects w/ Nephropathy
Source:
NephroGenex Inc.
Role:
Research Assistant
PI:
Blumenthal, Samuel S.
Dates:
10/2008 - 09/2010
 
Title:
A Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Randomized, Phase 2 Trial to Evaluate the Glycemic Efficacy, Renal safety, Pharmacokinetics, and Pharmacodynamics of Dapagliflozin in Subjects with Type II Diabetes Mellitus and Moderate Renal Impairment Who Have Inadequate Glycemic Control
Source:
Bristol-Myers Squibb/AstraZeneca
Role:
Research Assistant
PI:
Blumenthal, Samuel S.
Dates:
10/2008 - 09/2011
 
Title:
Evaluation of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE)
Source:
Amgen, Inc.
Role:
Research Coordinator
PI:
Blumenthal, Samuel S.
Dates:
10/2008 - 12/2012
 
Title:
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study Using Genz-644470 and Sevelamer Carbonate in Hyperphosphatemic Chronic Kidney Disease Patients on Hemodialysis
Source:
Genzyme Corporation
Role:
Research Assistant
PI:
Blumenthal, Samuel S.
Dates:
02/2009 - 09/2009
 
Title:
Evaluation of Monthly Darbepoetin alfa Dosing for the Treatment of Anemia in Chronic Kidney Disease (CKD) Patients Not Receiving Dialysis: An Active-controlled, Double-blind Study
Source:
Amgen Inc
Role:
Research Assistant
PI:
Blumenthal, Samuel S.
Dates:
08/2009 - 01/2010
 
Title:
PHX1149-PROT306: A Randomized, Double-Blind, Placebo- and Sitagliptin-Controlled, Multi-Center Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects with Moderate and Severe Renal Impairment Including Subjects on Hemodialysis
Source:
Phenomix Inc.
Role:
Research Assistant
PI:
Blumenthal, Samuel S.
Dates:
08/2009 - 12/2009
 
Title:
Randomized Evaluation of efficacy and safety of ferric carboxymaltose in Patients with iron deficiency Anemia and Impaired Renal function
Source:
Luitpold Pharmaceuticals, Inc.
Role:
Research Assistant
PI:
Blumenthal, Samuel S.
Dates:
09/2009 - 2011
 
Title:
An Exploratory Phase 2 Study to Assess the Effect of Dapagliflozin on Glomerular Filtration Rate (GFR) in Subjects with Type 2 Diabetes who have Inadequate Glycemic and Blood Prssure (BP) Control MB102-035
Source:
Bristol-Myers Squibb/AstraZeneca
Role:
Research Assistant
PI:
Blumenthal, Samuel S.
Dates:
09/2009 - 05/2011
 
Title:
A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (ferric citrate) in Patients with End-Stage Renal Disease (ESRD) Following a Two-Week Washout Period
Source:
Keryx Biopharmaceuticals
Role:
Research Coordinator
PI:
Blumenthal, Samuel S.
Dates:
12/2009 - 2011
 
Title:
A multicenter, randomized, double-blind, parallel group, active-controlled study to evaluate the efficacy and safety of LCZ696 compared to enalapril on morbidity and mortality in patients with chronic heart failure and reduced ejection fraction
Source:
Novartis Pharmaceuticals
Role:
Research Assistant
PI:
Ptacin, Michael
Dates:
12/2009 - 04/2014
 
Title:
H9V-MC-GFRF: A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients with Diabetic Kidney Disease due to Type 1 or Type 2 Diabetes
Source:
Eli Lilly & Co.
Role:
Research Coordinator
PI:
Blumenthal, Samuel S.
Dates:
06/2010 - 04/2014
 
Title:
A Three-Period, 58-Week Safety and Efficacy Trial of KRX-0502 (ferric citrate) in Patients with End-Stage Renal Disease (ESRD) on Dialysis
Source:
Keryx Biopharmaceuticals
Role:
Research Coordinator
PI:
Blumenthal, Samuel S.
Dates:
03/2011 - 2012
 
Title:
Bardoxolone methyl evaluation in patients with chronic kidney disease and type 2 diabetes: the occurrence of renal events (BEACON)
Source:
Reata Pharmaceuticals, Inc.
Role:
Research Coordinator
PI:
Blumenthal, Samuel S.
Dates:
09/2011 - 10/2012
 
Title:
A multi-centered, randomized, double-blind, placebo-controlled, Phase IV trial to evaluate the effect of saxigliptin on the incidence of cardiovascular death, myocardial infarction or ischemic stroke in patients with type 2 diabetes (SAVOR)
Source:
AstraZeneca
Role:
Research Coordinator
PI:
Blumenthal, Samuel S.
Dates:
2011 - 2013
 
Title:
A Long-Term Safety Extension Trial of KRX-0502 (ferric citrate) in Patients with End-Stage Renal Disease (ESRD) on Dialysis
Source:
Keryx Biopharmaceuticals
Role:
Research Coordinator
PI:
Blumenthal, Samuel S.
Dates:
2013 - 2014
 
Title:
Catechol-O-Methyltransferase (COMT) Enzyme Polymorphisms as a Predictor of Outcomes for Children with Septic Shock
Source:
Children’s Hospital of Wisconsin/Medical College of Wisconsin
Role:
Co-Investigator
PI:
Nathan Thompson, M.D., PharmD
Dates:
06/2017 - 01/2019
 
Title:
Nutrition Practices and Outcomes for Children on Non-Invasive Ventilation (NPO/NIV)
Source:
PALISI
Role:
Co-Investigator
PI:
Theresa Mikhailov, M.D., PharmD
Dates:
06/2017 - 06/2018
 
Title:
Prevention of Central Venous Associated – Thrombosis in Critically Ill Children (CRETE)
Source:
Yale School of Medicine/American Heart Association/Eunice Kennedy Shriver National Institute of Child Health and Human Development
Role:
Co-Investigator
PI:
Sheila Hanson, MD
Dates:
06/2018 - 06/2019
 

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
Greenley RN, Doughty A, Medication Adherence and Barriers to Adherence Among Teens with Inflammatory Bowel Disease, Annual Department of Pediatrics Summer Research Student Fair, Milwaukee, WI, 07/2008
Children's Wisconsin, Monthly Administrative Meeting, Educational Session, 04/2017 - Present
 

PEER REVIEWED WORKSHOPS/PRESENTATIONS:
Local
Journal Club – Cranial Computed Tomographic Findings in a Large Group of Children with Drowning: Diagnostic, Prognostic, and Forensic Implications, Pediatric Nurse Practitioner Monthly Administration Meeting - Educational Session, Children's Hospital of Wisconsin, 11/06/2015
Journal Club – Pediatric ARDS Part 1, Pediatric Nurse Practitioner Monthly Administration Meeting - Educational Session, Children's Hospital of Wisconsin, 02/15/2016
Journal Club– Use of Methylene Blue in Septic Shock, Pediatric Nurse Practitioner Monthly Administration Meeting - Educational Session, Children's Hospital of Wisconsin, 08/15/2016
Journal Club – Kounis: A Case Report, Journal Club– Use of Methylene Blue in Septic Shock, Children's Hospital of Wisconsin, 04/17/2017
New Critical Care Nurse Education Course - ARDS, Journal Club– Use of Methylene Blue in Septic Shock, Children's Hospital of Wisconsin, 10/17/2017
New Critical Care Nurse Education Course - ARDS, Journal Club– Use of Methylene Blue in Septic Shock, Children's Hospital of Wisconsin, 04/17/2018
 

COMMITTEE SERVICE:
Medical College of Wisconsin
2015 - 05/2017 Member, Pediatric Critical Care Education Group - Ultrasound Guided Procedures, Medical College of Wisconsin
2015 - Present Co-Lead, Pediatric Critical Care PNP Journal Club and Educational Series, Medical College of Wisconsin
2016 - Present Member, PNP Representative, Critical Care Fellow Clinical Competency Committee, Children's Wisconsin/ Medical College of Wisconsin
2019 - Present Member/ PNP Representative, Critical Care Research Operations Committee (CCROC), Medical College of Wisconsin
 
Hospital
2017 - Present Member, Medication Reconciliation Committee, Children's Hospital of Wisconsin
2017 - Present Member, Pediatric ARDS Guideline Development Team, Children's Wisconsin
2018 - Present Member, 24 Hour Readmission to PICU Committee, Children's Wisconsin
2019 - Present Member, TBR Summit Planning Committee
2019 - Present Member, PICU Code Committee, Children's Wisconsin
2019 - Present Member, PICU Intra-PICU Transfer Workgroup, Children's Wisconsin
 

EXTRAMURAL TEACHING:
Continuing Medical Education
07/2015 - Present Medical College of Wisconsin/Children's Hospital of Wisconsin, Instructor - Pediatric Fundamental of Critical Care Support (PFCCD)
 
Graduate Student Education
2015 - Present Marquette University, Acute Care Pediatric Nurse Practitioners
 

EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED:
Clinical Staff
Laura Lerner, CPNP-AC, Medical College of Wisconsin/Children's Hospital of Wisconsin, 11/2015 - 03/2016 Preceptor
Nathan Neis, CPNP-AC, Medical College of Wisconsin/Children's Hospital of Wisconsin, 10/2016 - 04/2017 Preceptor
 


BIBLIOGRAPHY
Non-Refereed Journal Publications/Original Papers
1. Greenley RN, Stephens M, Doughty A, Raboin T, Kugathasan S. Barriers to adherence among adolescents with inflammatory bowel disease. Inflamm Bowel Dis. 2010 Jan;16(1):36-41.
2. Greenley RN, Doughty A, Stephens M, Kugathasan S. Brief report: development of the inflammatory bowel disease family responsibility questionnaire. J Pediatr Psychol. 2010 Mar;35(2):183-7.
 
Abstracts
1. Greenley RN, Doughty A Medication Adherence and Barriers to Adherence Among Teens with Inflammatory Bowel Disease .